DUBLIN--(BUSINESS WIRE)--The "3D Bioprinting Market Size, Share & Trends Analysis Report By Technology (Magnetic Levitation, Inkjet-based, Syringe-based, Laser-based), By Application (Medical, Dental, Biosensors, Bioinks), And Segment Forecasts, 2019 - 2026" report has been added to ResearchAndMarkets.com's offering.
The global 3D bioprinting market is expected to reach USD 2.6 billion by 2024.
Growing use of 3D printing in cosmetic surgery and drug testing coupled with increasing demand for 3D bio-printed organs is expected to drive the market growth during the forecast period.
Currently, 3D bioprinting is used for printing medical instruments, prosthetics, and dental & bone implants. However, its application is expected to grow in pharmaceutical manufacturing as it helps in reducing the overall cost of drug manufacturing.
Spritam (levetiracetam) manufactured by Aprecia Pharmaceutical, a specialty pharmaceutical company, became the first 3D bio-printed drug to gain FDA approval in March 2016. The application of 3D bioprinting in pharmaceutical manufacturing is expected to grow, thereby, contributing to the market growth during the forecast period.
Rising incidences of chronic illnesses leading to organ and tissue transplants coupled with the increasing life span of individuals and limited number of organ donors are expected to be the major drivers for the market growth. The advancement in technology and incorporation of IT within the healthcare industry, rising geriatric population base, and improving R&D efforts for the sector is also expected to propel the 3D bioprinting market over the forecast period.
Rising investment and research in 3D bioprinting is also expected to contribute to the market growth during the forecast period. The increasing R&D expenditure, availability of venture capital, and government grants are facilitating research activities in the 3D bioprinting technology. This is expected to increase the influx of advanced technologies for 3D bioprinting.
Further key findings from the report suggest:
- The global Syringe based 3D bioprinting market is anticipated to reach 923.5 million by 2024, at a CAGR of 17.8% from 2016 to 2024
- In terms of technology, magnetic levitation segment is expected to show the fastest growth during the forecast period
- In terms of application, dental segment is expected to show the fastest growth over the forecast period
- North America is expected to dominate the 3D bioprinting market during the forecast period
- Asia pacific is predicted to show the fastest growth in 3D bioprinting market over the forecast period
- The market is partially consolidated and competitive in nature, with presence of global multinational players
- Some of the key companies present in the market include Organovo Holding Inc., Cyfuse Biomedical, BioBots, Luxexcel Group BV, TeVido BioDevices, Aspect Biosystems, 3Dynamics Systems, Stratasys Ltd., Voxeljet, Oceanz, Materialise NV, Envision TEC, Bio3D Technologies, Solidscape and others
Key Topics Covered
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. 3D Bioprinting Market - Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. 3D Bioprinting Market Industry Outlook
3.1. 3D Bioprinting Market: Segmentation
3.2. 3D Bioprinting Market: Size And Growth Prospects
3.3. 3D Bioprinting Value Chain Analysis
3.4. 3D Bioprinting Market: Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.5. Key Opportunities Prioritized
3.6. Industry Analysis - Porter's
3.7. 3D Bioprinting Company Market Share, 2015
3.8. 3D Bioprinting Market: PESTEL Analysis, 2015
3.9. 3D Bioprinting Future Prospects
3.10. 3D Bioprinting Technology Overview
Chapter 4. 3D Bioprinting Market Technology Outlook
4.1. 3D Bioprinting Market Share, By Technology, 2015 & 2024
4.2. Magnetic Levitation 3D Bioprinting
4.3. Inkjet Based 3D Bioprinting
4.4. Syringe Based 3D Bioprinting
4.5. Laser Based 3D Bioprinting
Chapter 5. 3D Bioprinting Market Application Outlook
5.1. 3D Bioprinting Market Share, By Application, 2015 & 2024
5.5. Consumer/Personal Product Testing
5.7. Food And Animal Product
Chapter 6. 3D Bioprinting Market Regional Outlook
6.1. 3D Bioprinting Market Share, By Region, 2015 & 2024
6.2. North America
6.4. Asia Pacific
6.5. Latin America
Chapter 7. Competitive Landscape
7.1. 3D Systems
7.4. Envision TEC
7.5. Materialise NV
7.6. Bio3D Technologies
7.7. Oceanz 3D printing & Additive Manufacturing
7.9. Stratasys Ltd.
7.11. Luxexcel Group BV
7.12. TeVido BioDevices
7.13. 3Dynamics Systems
7.14. Aspect Biosystems
7.16. Cyfuse Biomedical
For more information about this report visit https://www.researchandmarkets.com/r/lvj98g